What is C2DX?
Founded in 2019, C2DX operates within the medical device sector, focusing on the strategic acquisition and enhancement of specialized products. The company's mission is to improve the accessibility and efficacy of valuable medical technologies worldwide, underpinned by a commitment to superior customer service and continuous innovation. C2Dx aims to equip healthcare providers with essential devices and cutting-edge technology.
How much funding has C2DX raised?
C2DX has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in C2DX
PPP
Public-Private Partnership
What's next for C2DX?
With a substantial capital infusion and a clear focus on late-stage growth, C2DX is poised for accelerated expansion. The recent strategic investment likely signals confidence from backers in the company's business model and market potential. This backing will enable C2DX to further refine its product delivery systems, broaden its market reach, and potentially explore new therapeutic areas or technological advancements within the medical device landscape. The company's trajectory suggests a continued emphasis on scaling operations and solidifying its position as a key provider of niche medical solutions.
See full C2DX company page
